AlloVir
Stock Forecast, Prediction & Price Target
AlloVir Financial Estimates
AlloVir Revenue Estimates
AlloVir EBITDA Estimates
AlloVir Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $2.61M Low: $2.61M High: $2.61M avg. 0% | Avg: $160.23M Low: $160.23M High: $160.23M avg. 6035.12% | Avg: $770.77M Low: $770.77M High: $770.77M avg. 381.02% | Avg: $1.17B Low: $1.17B High: $1.17B avg. 51.91% |
Net Income
% change YoY
| $-171.96M N/A | $-168.71M 1.89% | $-190.41M -12.86% | Avg: $-43.27M Low: $-69.71M High: $-6.24M avg. 77.27% | Avg: $-53.87M Low: $-47.86M High: $-47.86M avg. -24.50% | Avg: $-47.86M Low: $-47.86M High: $-47.86M avg. 11.15% | Avg: $-47.86M Low: $-47.86M High: $-47.86M avg. 0% |
EBITDA
% change YoY
| $-169.81M N/A | $-171.20M -0.81% | $-190.14M -11.06% | Avg: $1.56M Low: $1.56M High: $1.56M avg. 100.82% | Avg: $96.14M Low: $96.14M High: $96.14M avg. 6035.12% | Avg: $462.46M Low: $462.46M High: $462.46M avg. 381.02% | Avg: $702.55M Low: $702.55M High: $702.55M avg. 51.91% |
EPS
% change YoY
| -$2.74 N/A | -$2.2 19.70% | -$1.83 16.81% | Avg: -$0.37 Low: -$0.67 High: -$0.06 avg. 79.78% | Avg: -$0.46 Low: -$0.46 High: -$0.46 avg. -24.32% | Avg: -$0.46 Low: -$0.46 High: -$0.46 avg. 0% | Avg: -$0.46 Low: -$0.46 High: -$0.46 avg. 0% |
Operating Expenses
% change YoY
| $169.81M N/A | $171.20M 0.81% | $180.93M 5.68% | Avg: $35.70M Low: $35.70M High: $35.70M avg. -80.26% | Avg: $2.19B Low: $2.19B High: $2.19B avg. 6035.12% | Avg: $10.53B Low: $10.53B High: $10.53B avg. 381.02% | Avg: $16.00B Low: $16.00B High: $16.00B avg. 51.91% |
FAQ
What is AlloVir stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.98% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -69.71M, average is -43.27M and high is -6.24M.
What is AlloVir stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1617.01% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $2.61M, average is $2.61M and high is $2.61M.
What is AlloVir stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 13.86% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.67, average is -$0.37 and high is $-0.06.
What is the best performing analyst?
In the last twelve months analysts have been covering AlloVir stock. The most successful analyst is Christopher Raymond.